Tagged with M

UK   The Ambassador of Switzerland to the UK, Alexandre Fasel, discloses what has been achieved so far with the ‘Mind the Gap’ strategy, aimed at safeguarding British-Swiss economic and business relations after Brexit. Fasel further highlights innovation as being part of the common DNA of Switzerland and the UK, and…

India Mohal Sarabhai, a serial entrepreneur and grandson of the illustrious scientist and industrialist Vikram Sarabhai, provides insights into the eye-catching group of companies he has been developing over the past 15 years, ranging from the effervescent products specialist Vovantis to the fermentation-focused API manufacturer Synbiotics. He also documents his two-fold…

Malta Denis Borg, secretary general of the Maltese Italian Chamber of Commerce, discusses the central role of the chamber in developing business between Malta and Italy and explains how Malta’s attractiveness for Italian companies originates from being a welcoming entrepreneurial environment with a favorable location. Can you describe the role and…

Malta Nicholas Falzon and Margot Pisani, respectively president and secretary general at the Pharmaceutical Research-based Industry Malta Association (PRIMA), discuss the business environment for originators in the island as well as the efforts of the government to provide more innovative solutions to Maltese patients. Can you please introduce yourself to our…

India Vivek Sharma, CEO of Piramal Pharma Solutions (PPS), one of the world’s leading CDMOs with a presence in North America, Europe, and Asia, provides insights into the main trends shaping the global demand for contract development and manufacturing services. He also highlights the company’s customer-centric business model, the strength of…

Portugal Paulo Teixeira shines a light on Pfizer’s promising pipeline for 2018, the market access environment in Portugal and the clinical trial landscape. Teixeira intends to contribute to improving society’s perception of the pharmaceutical industry and position Pfizer as a partner for health and wellbeing in Portugal; part of the solution—not…

UK After a series of recent acquisitions, developing a diverse portfolio comprising four business areas; including OTC and branded prescription medicines, Mylan UK’s country manager, Jean-Yves Brault, takes a step back and analyses the new Mylan, while highlighting how it is fit for the future of healthcare. How does Mylan position…

Portugal João Vasconcelos was the Secretary of State for Industry in Portugal over a two year period, terminating in July 2017, over which time he laid the foundations for Startup Portugal and Industry 4.0. In this interview, Vasconcelos discusses the historical reasons behind Portugal’s success, digitalization and why more and more…

Pharma While drug developers, healthcare practitioners and patients all rejoice at the advent of a golden age of scientific advancement in medicine – symbolized by recent radical breakthroughs in all manners of domains from stem cells and CAR-T generation immunotherapy to gene tech and 3D bio-printing – it is clear that…

Portugal Pedro Moura is the first Portuguese managing director of Merck in Portugal, taking on the role in September 2017 after a stint in HQ in Darmstadt, Germany. Moura discusses Merck’s global vision, new and exciting products coming soon to the Portuguese market and the importance of collaborative partnerships across the…

UK Hugo Fry, managing director of Sanofi UK, details the impact of the company’s changing structure, the continued relevance of the UK market despite the challenges around Brexit, and the significance of vaccine R&D and production in the UK.   We have a broad portfolio, from the very first vaccine that…

Portugal Enrique Santos, president of the Spanish Chamber of Commerce in Portugal since 1998, observes the rapid change in the volume and nature of investments into Portugal in recent years. Santos explains the historical partnership formed on the Iberian Peninsula, the excellent quality of life experienced across the country and the…